Banner Corporation (NASDAQ GSM: BANR) has announced the addition of Mark Borrecco as the Chief Banking Officer. Borrecco is now responsible for overseeing the Bank’s production lines of business, ...

Wells Fargo & Company (NYSE: WFC) has issued a statement regarding a formal agreement between Wells Fargo Bank, N.A. and the Office of the Comptroller of the Currency (OCC) related to the bank’s ...

Additionally, in accordance with the terms of Redwood's 10.00% Series A Fixed-Rate Reset Cumulative Redeemable Preferred Stock ("Series A"), the board has authorized the declaration of a Series A ...

Agilent Technologies sank -2.1% today, compared to the S&P 500's day change of 1.0%. Today's losers may turn out to be tomorrow's winners, so be sure to check the stock's fundamentals before making an ...

Philip Morris International Inc. has announced an increase in its regular quarterly dividend by 3.8% to an annualized rate of $5.40 per share. The new quarterly dividend of $1.35 per share, up from $1 ...

Today the company's shares have moved 23.6% to a price of $25.99. For the full picture, make sure to review Lovesac's 10-Q report.

Mark Grescovich, President & Chief Executive Officer, stated that Borrecco’s extensive experience and leadership style make him a great fit for Banner. Borrecco has over 25 years of banking experience ...

Victory Capital Holdings, Inc. has reported its total client assets for August 2024, revealing key changes from the previous period. As of August 31, 2024, the company's total assets under management ...

Standing out among the Street's worst performers today is Marathon Petroleum, a oil & gas integrated company whose shares slumped -3.0% to a price of $158.61, 17.42% below its average analyst target ...

Aura Biosciences, Inc. (NASDAQ: AURA) has reported positive phase 2 end of study results for their first-line treatment of early-stage choroidal melanoma (CM) using Bel-sar (AU-011). The results were ...

Troy R. Anderson has been named the executive vice president and chief financial officer designate, effective from October 14, 2024. He will succeed Olivier Thirot, who informed the company of his ...

In early 2023, Dr. Simon assumed a new role to accelerate innovation across CHS and has since implemented various technologies and programs aimed at improving care delivery and patient experiences.